Revel Michel

NLS Pharmaceutics AG · CSO and Director

Revel Michel is listed in public filings as director, 10 percent owner, officer: CSO and Director. This Revel Michel insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include NLS Pharmaceutics AG (NLSPW). Investors use Revel Michel's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
NLS Pharmaceutics AGNLSPW$231k76.4k sharesBuyApr 27, 2026$3.03--
NLS Pharmaceutics AGNLSPW$150k54.5k sharesBuyApr 27, 2026$2.75--